Antiviral Agents/pharmacology; Coronavirus Infections/drug therapy; Coronavirus/drug effects; Drug Evaluation, Preclinical; Pneumonia, Viral/drug therapy; Pneumonia, Viral/virology; Severe Acute Respiratory Syndrome/drug therapy; Angiotensin-Converting Enzyme 2; Animals; Antiviral Agents/supply & distribution; Antiviral Agents/therapeutic use; COVID-19; China/epidemiology; Clinical Trials as Topic; Coronavirus Infections/epidemiology; Coronavirus Infections/veterinary; Coronavirus Infections/virology; Disease Models, Animal; Humans; Mice; Middle East Respiratory Syndrome Coronavirus/drug effects; Patient Selection; Peptidyl-Dipeptidase A/genetics; Peptidyl-Dipeptidase A/metabolism; Pneumonia, Viral/epidemiology; Pneumonia, Viral/veterinary; Severe acute respiratory syndrome-related coronavirus/drug effects; Severe Acute Respiratory Syndrome/virology; Time Factors; COVID-19 Drug Treatment

Diseases; Infection; Virology